Rezapour, Aziz; Souresrafil, Aghdas; Peighambari, Mohammad Mehdi; Heidarali, Mona; Tashakori-Miyanroudi, Mahsa
International journal of surgery (London, England)
2021Jan ; 85 ( 4 ) :10-18.
PMID : 33227532
ÀúÀÚ »ó¼¼Á¤º¸
Rezapour, Aziz - Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. Electronic address: rezapour.a@iums.ac.ir.
Souresrafil, Aghdas - Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. Electronic address: souresrafil.a@iums.ac.ir.
Peighambari, Mohammad Mehdi - Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: mehdipei@gmail.com.
Heidarali, Mona - Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: monami_58@yahoo.co.uk.
Tashakori-Miyanroudi, Mahsa - Department of Medical Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: mhs_tashakori@yahoo.com.
ABSTRACT
BACKGROUND: The COVID-19 pandemic has become a public health emergency and raised global concerns in about 213 countries without vaccines and with limited medical capacity to treat the disease. The COVID-19 has prompted an urgent search for effective interventions, and there is little information about the money value of treatments. The present study aimed to summarize economic evaluation evidence of preventing strategies, programs, and treatments of COVID-19. MATERIAL AND
METHODS: We searched Medline/PubMed, Cochrane Library, Web of Science Core Collection, Embase, Scopus, Google Scholar, and specialized databases of economic evaluation from December 2019 to July 2020 to identify relevant literature to economic evaluation of programs against COVID-19. Two researchers screened titles and abstracts, extracted data from full-text articles, and did their quality assessment by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Then, quality synthesis of results was done.
RESULTS: Twenty-six studies of economic evaluations met our inclusion criteria. The CHEERS scores for most studies (n?=?9) were 85 or higher (excellent quality). Eight studies scored 70 to 85 (good quality), eight studies scored 55 to 70 (average quality), and one study?
keyword
COVID-19; Economic evaluation; Isolation; Lockdown; SARS-COV-2; Screening
MESH
COVID-19/diagnosis/*economics/*prevention & control, COVID-19 Testing/economics, *Cost-Benefit Analysis, Global Health/*economics, Humans, Pandemics/economics/*prevention & control, Personal Protective Equipment/economics, Physical Distancing
¸µÅ©